Gilead Sciences, Inc.

13F Holdings History for Kalaris Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KLRS)

Symbol: KLRS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership: 723K shares
Security Ownership: 3.9%

Shares, Excluding Options vs Price

Value, Excluding Options

GILEAD SCIENCES, INC. ownership in Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS)

2025-03-20 - GILEAD SCIENCES, INC. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 723K shares of Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS). This represents 3.9% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
GILEAD SCIENCES, INC.	3.9%		$5.81M	723K			$8.03	13G/A	3/18/2025	20 Mar 2025 16:32:25

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025		-0.07%	$0	0	-317,789	-100%		Q3 2025
6/30/2025	0.07%	-0.08%	$848K	318K	-405,484	-56.1%	$2.67	Q2 2025
3/31/2025	0.49%	+0.49%	$5.81M	723K	+723,273	NEW	$8.03	Q1 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.